# | Title | Journal | Year | Citations |
---|
|
1 | EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma | Journal of Hepatology | 2018 | 6,663 |
2 | EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma | Journal of Hepatology | 2012 | 5,301 |
3 | Histological grading and staging of chronic hepatitis | Journal of Hepatology | 1995 | 4,754 |
4 | EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection | Journal of Hepatology | 2017 | 4,067 |
5 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference | Journal of Hepatology | 2001 | 3,993 |
6 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Journal of Hepatology | 2016 | 3,617 |
7 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection | Journal of Hepatology | 2012 | 2,811 |
8 | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Journal of Hepatology | 1999 | 2,722 |
9 | Expanding consensus in portal hypertension | Journal of Hepatology | 2015 | 2,703 |
10 | Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies | Journal of Hepatology | 2006 | 2,542 |
11 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 2,487 |
12 | Burden of liver diseases in the world | Journal of Hepatology | 2019 | 2,349 |
13 | The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Journal of Hepatology | 2006 | 2,245 |
14 | NAFLD: A multisystem disease | Journal of Hepatology | 2015 | 2,190 |
15 | BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update | Journal of Hepatology | 2022 | 1,946 |
16 | EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis | Journal of Hepatology | 2018 | 1,926 |
17 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B | Journal of Hepatology | 2009 | 1,713 |
18 | Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension | Journal of Hepatology | 2010 | 1,688 |
19 | Global epidemiology and genotype distribution of the hepatitis C virus infection | Journal of Hepatology | 2014 | 1,596 |
20 | EASL Clinical Practice Guidelines: Management of cholestatic liver diseases | Journal of Hepatology | 2009 | 1,568 |
21 | EASL Recommendations on Treatment of Hepatitis C 2018 | Journal of Hepatology | 2018 | 1,538 |
22 | EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis | Journal of Hepatology | 2015 | 1,532 |
23 | EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis | Journal of Hepatology | 2010 | 1,526 |
24 | Non-alcoholic fatty liver disease – A global public health perspective | Journal of Hepatology | 2019 | 1,497 |
25 | Liver fibrosis – from bench to bedside | Journal of Hepatology | 2003 | 1,470 |
26 | Classification of chronic viral hepatitis: a need for reassessment | Journal of Hepatology | 1991 | 1,434 |
27 | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis | Journal of Hepatology | 2019 | 1,419 |
28 | Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy | Journal of Hepatology | 2003 | 1,339 |
29 | Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030 | Journal of Hepatology | 2018 | 1,293 |
30 | Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma | Journal of Hepatology | 2014 | 1,206 |
31 | Non-invasive evaluation of liver fibrosis using transient elastography | Journal of Hepatology | 2008 | 1,201 |
32 | Baveno VII – Renewing consensus in portal hypertension | Journal of Hepatology | 2022 | 1,166 |
33 | Complications following percutaneous liver biopsy | Journal of Hepatology | 1986 | 1,139 |
34 | Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors | Journal of Hepatology | 2008 | 1,124 |
35 | The burden of liver disease in Europe: A review of available epidemiological data | Journal of Hepatology | 2013 | 1,106 |
36 | Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease | Journal of Hepatology | 2015 | 1,106 |
37 | The gut-liver axis in liver disease: Pathophysiological basis for therapy | Journal of Hepatology | 2020 | 1,096 |
38 | EASL Clinical Practice Guidelines: Management of hepatitis C virus infection | Journal of Hepatology | 2011 | 1,088 |
39 | Criteria of drug-induced liver disorders | Journal of Hepatology | 1990 | 1,083 |
40 | EASL Recommendations on Treatment of Hepatitis C 2015 | Journal of Hepatology | 2015 | 1,063 |
41 | Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis | Journal of Hepatology | 2016 | 1,029 |
42 | EASL Clinical Practice Guidelines: Wilson’s disease | Journal of Hepatology | 2012 | 1,018 |
43 | Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension | Journal of Hepatology | 2005 | 994 |
44 | Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis | Journal of Hepatology | 2000 | 978 |
45 | Endoplasmic reticulum stress in liver disease | Journal of Hepatology | 2011 | 973 |
46 | EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis | Journal of Hepatology | 2017 | 962 |
47 | EASL Clinical Practice Guidelines: Autoimmune hepatitis | Journal of Hepatology | 2015 | 961 |
48 | EASL Recommendations on Treatment of Hepatitis C 2016 | Journal of Hepatology | 2017 | 955 |
49 | A position statement on NAFLD/NASH based on the EASL 2009 special conference | Journal of Hepatology | 2010 | 928 |
50 | Treatment of NAFLD with diet, physical activity and exercise | Journal of Hepatology | 2017 | 923 |